Evidence map›Paper›PMID 33258947›Full record

ArticleNeuro-oncology2021

Conditional reprogramming culture conditions facilitate growth of lower-grade glioma models.

Ming Yuan, David White, Linda Resar, Eli Bar, Mari Groves, Alan Cohen, Eric Jackson, Jennifer Bynum, Jeffrey Rubens, Jeff Mumm and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. MOST wanted: navigating the MAPK-OIS-SASP-tumor microenvironment axis in primary pediatric low-grade glioma and preclinical models.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Stem cell modeling of nervous system tumors.Disease models & mechanisms · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Biobanked tracheal basal cells retain the capacity to differentiate.Laryngoscope investigative otolaryngology · 2022
    Article
  20. Zebrafish Models of Paediatric Brain Tumours.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Ming YuanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
David WhiteDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Linda ResarDivision of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Eli BarDepartment of Pathology, University of Maryland, Baltimore, Maryland, USA.
Mari GrovesDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Alan CohenDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Eric JacksonDepartment of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jennifer BynumDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jeffrey RubensDivision of Pediatric Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jeff MummDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Liam ChenDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Liqun JiangDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Eric RaabeDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Fausto J RodriguezDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Charles G EberhartDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Maryland, Baltimore · US

Funding

Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI Ji Yi · 1985 to 2026
$22.1M
Visual Science Training ProgramT32EY007143 · NEI · JOHNS HOPKINS UNIVERSITY · PI Laura Ensign, JEREMY NATHANS · 1995 to 2026
$6.2M
HMGA Chromatin Remodeling Proteins in Tumor Progression in Myeloproliferative Neoplasms (MPN)R01HL145780 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MOLITERNO, ALISON R, RESAR, LINDA M S · 2018 to 2021
$1.9M
The HMGA1 Chromatin Regulator in Hematopoietic Stem Cells with AgingR01DK102943 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI RESAR, LINDA M S · 2017 to 2019
$884k
NEI NIH HHS P30 EY001765NEI NIH HHS T32 EY007143NHLBI NIH HHS R01 HL145780NIDDK NIH HHS R01 DK102943
6 · The paper itself

Abstract

backgroundThe conditional reprogramming cell culture method was developed to facilitate growth of senescence-prone normal and neoplastic epithelial cells, and involves co-culture with irradiated fibroblasts and the addition of a small molecule Rho kinase (ROCK) inhibitor. The aim of this study was to determine whether this approach would facilitate the culture of compact low-grade gliomas.

methodsWe attempted to culture 4 pilocytic astrocytomas, 2 gangliogliomas, 2 myxopapillary ependymomas, 2 anaplastic gliomas, 2 difficult-to-classify low-grade neuroepithelial tumors, a desmoplastic infantile ganglioglioma, and an anaplastic pleomorphic xanthoastrocytoma using a modified conditional reprogramming cell culture approach.

resultsConditional reprogramming resulted in robust increases in growth for a majority of these tumors, with fibroblast conditioned media and ROCK inhibition both required. Switching cultures to standard serum containing media, or serum-free neurosphere conditions, with or without ROCK inhibition, resulted in decreased proliferation and induction of senescence markers. Rho kinase inhibition and conditioned media both promoted Akt and Erk1/2 activation. Several cultures, including one derived from a NF1-associated pilocytic astrocytoma (JHH-NF1-PA1) and one from a BRAF p.V600E mutant anaplastic pleomorphic xanthoastrocytoma (JHH-PXA1), exhibited growth sufficient for preclinical testing in vitro. In addition, JHH-NF1-PA1 cells survived and migrated in larval zebrafish orthotopic xenografts, while JHH-PXA1 formed orthotopic xenografts in mice histopathologically similar to the tumor from which it was derived.

conclusionsThese studies highlight the potential for the conditional reprogramming cell culture method to promote the growth of glial and glioneuronal tumors in vitro, in some cases enabling the establishment of long-term culture and in vivo models.

Indexed as

AstrocytomaBrain NeoplasmsCellular ReprogrammingGliomaAnimalsCell Culture TechniquesMiceProto-Oncogene Proteins B-rafZebrafishProto-Oncogene Proteins B-rafBRAFV600Econditional reprogrammingenescencelow-grade gliomaNF1

Identifiers

PMID33258947
PMCPMC8099469
OpenAlexW3110645383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.